Pfizer joins Sanofi on the C. difficile failure train after its vaccine flopped a PhIII study
Big Pharma has been trying to come up with a vaccine for C. difficile infection for years, but one more program joined the heap of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
